LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-07. Numbers and descriptions here follow the published literature rather than marketing material.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
| Property | Value | Notes |
|---|---|---|
| Appearance | Off-white to pale yellow solid | Visual description varies with purity and source |
| Solubility | Soluble in DMSO and ethanol; poorly soluble in water | Organic stock solutions are common in research |
| Typical storage | -20 °C, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Typical analytical method | LC-MS or HPLC-UV | Reference standards are needed for quantification |
| Molar mass | Approximately 437.9 g/mol | Calculated from the reported free-base formula |
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
== YouTube career == Pansino began her YouTube channel in 2010 after she was encouraged by a few of her friends who also worked on YouTube, and she started making videos to get more comfortable in front of a camera. After her early baking videos gained a steady following, viewers eventually started to request more content. Because she had never seen a baking show on television or the Internet, Pansino decided to create the Nerdy Nummies series. She decided to use the last name "Pansino" online, which was her maternal grandmother’s maiden name. She later revealed that in her early years of YouTube, while she was still working as an actress, she was given the ultimatum by her agent to choose between acting and YouTube. She remained adamant that she would not quit YouTube, despite the uncertainty involved. Pansino told Cosmopolitan in 2015: "At this point, I wasn't making any money on YouTube. I knew that it was possible to do that but I wasn't making a dime. I decided, I'm going to do this. I'm not going to let YouTube go." As of April 2026, Pansino's channel has attained over 5.1 billion views and 14.8 million subscribers, making it the most popular cooking channel on YouTube. She has received several accolades. In 2013, she won the Shorty Award for Best Foodie, Chef, or Food Lover in Social Media. She has also received five Streamy Award nominations for her work on Nerdy Nummies. In 2018, Pansino officially reached 10 million subscribers on YouTube, earning her the Diamond Play Button given by the company.
Culture Secretary Lucy Frazer holds an urgent meeting with BBC Director General Tim Davie at which he tells her the BBC is investigating the matter "swiftly and sensitively". The BBC subsequently confirms it has suspended the presenter and referred the matter to the police. 10 July A lawyer representing the young person who was allegedly paid by a BBC presenter for indecent photographs casts doubt on the story. In a letter to the BBC, the lawyer says that his client contacted The Sun on 7 July to tell the newspaper there was "no truth in it". The paper is said to have subsequently printed the "inappropriate article" containing allegations made by the client's mother. EasyJet announces the cancellation of 1,700 flights to and from Gatwick Airport during July, August and September, citing constraints on airspace in Europe and ongoing traffic control difficulties. 11 July A second young person comes forward to make allegations about the BBC presenter at the centre of a scandal, claiming that they were contacted by him on a dating app and sent abusive and threatening messages. The person, in their early 20s, also says they felt under pressure to meet up, although they did not do so. The average deal on a two-year fixed mortgage reaches 6.66%, the highest level since the 2008 financial crisis. 12 July Huw Edwards is identified by his wife as the BBC presenter being investigated for allegedly paying a 17-year-old for sexually explicit photos.
=== N- and C-termini === The peptides matched during protein identification do not necessarily include the N- or C-termini predicted for the matched protein. This may result from the N- or C-terminal peptides being difficult to identify by MS (e.g. being either too short or too long), being post-translationally modified (e.g. N-terminal acetylation) or genuinely differing from the prediction. Post-translational modifications or truncated termini may be identified by closer examination of the data (i.e. de novo sequencing). A repeat digest using a protease of different specificity may also be useful.
=== Dose reconstruction with ESR spectroscopy of deciduous teeth === As a result of accidents or improper use and disposal of radiation sources, a significant number of people are exposed to varying degrees of radiation. Radioactivity and local dose measurements are not sufficient to fully assess the effects of radiation. To retrospectively determine the individual radiation dose, measurements are made on teeth, i.e. on biological, endogenous materials. Tooth enamel is particularly suitable for the detection of ionizing radiation due to its high mineral content (hydroxyapatite), which has been known since 1968 thanks to the research of John M. Brady, Norman O. Aarestad and Harold M. Swartz. The measurements are performed on milk teeth, preferably molars, using electron paramagnetic resonance spectroscopy (ESR, EPR). The concentration of radicals generated by ionizing radiation is measured in the mineral part of the tooth. Due to the high stability of the radicals, this method can be used for dosimetry of long past exposures.
=== Inhibition of ACTH production === Corticotropes contain glucocorticoid receptors (GRs) and corticosteroid-binding globulin (CBG, or transcortin). GR is a nuclear receptor that inhibits transcription of ACTH via a negative glucocorticoid recognition element (GRE) that binds cortisol on POMC DNA, but generally transcortin binds glucocorticoids (including cortisol, cortisone, deoxycortisone, and aldosterone) with high affinity and prevents this inhibition. Tonic inhibition of corticotropes requires high concentrations of glucocorticoids, exceeding CBG capacity. This causes ACTH secretion to be vulnerable to inhibition in patients taking glucocorticoids for medical purposes such as treatment of autoimmune disease or as an anti-transplant-rejection medication.
Sources: en.wikipedia.org
== External links == Fibronectin, an Extracellular Adhesion Molecule The Fibronectin Protein Fibronectin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Fibronectin molecular interactions Overview of all the structural information available in the PDB for UniProt: P02751 (Human Fibronectin) at the PDBe-KB. Overview of all the structural information available in the PDB for UniProt: P11276 (Mouse Fibronectin) at the PDBe-KB.
=== Potential interactions === Several adverse interactions with drugs have been documented, both prescription and nonprescription, including, but not limited to: anticonvulsants, alcohol, anxiolytics (central nervous system depressants such as benzodiazepines), antipsychotics, levodopa, diuretics, and drugs metabolized by CYP450 in the liver. A few notable potential drug interactions are:
== Deaths == 1 January – Sally Oppenheim-Barnes, Baroness Oppenheim-Barnes, 96, British politician, minister of state for consumer affairs (1979–1982), MP (1970–1987), and member of the House of Lords (1989–2019). 4 January – Jenny Randerson, Baroness Randerson, 76, Welsh politician and peer, acting Deputy First Minister of Wales (2001–2002) and member of the House of Lords (since 2011). 24 January – Joan Hanham, Baroness Hanham, 85, British politician, member of the House of Lords (1999–2020) and leader of the Kensington and Chelsea Council (1989–2000). 1 February – John Montagu, 11th Earl of Sandwich, 81, British aristocrat, businessman and politician, member of the House of Lords (1995–2024). 7 February – Dafydd Elis-Thomas, Baron Elis-Thomas, 78, Welsh politician, llywydd of the Senedd (1999–2011), MP (1974–1992) and member of the House of Lords (since 1992). 16 February – Barry Panter, politician (Mayor of Newcastle-under-Lyme), car crash. (death reported on this date) 19 February – Joe Haines, 97, British journalist and public servant, Downing Street press secretary (1969–1970, 1974–1976). 27 March – Christina McKelvie, 57, Scottish politician, MSP (since 2007), minister for culture (2023–2024) and drugs and alcohol policy (since 2024), breast cancer. 30 March – Stanley Kalms, Baron Kalms, 93, British businessman, chairman of Currys, and life peer, member of the House of Lords (2004–2024). 31 March – Janric Craig, 3rd Viscount Craigavon, 80, British hereditary peer and member of the House of Lords (since 1974) 23 April – Peter Taaffe, 83, British Marxist militant.
In 2017, the United Nations conducted a Bayesian sensitivity analysis of global population burden based on life expectancy projection at birth in future decades. The 95% prediction interval of average life expectancy rises as high as 106 years old by 2090, with ongoing and layered effects on world population and demography should that happen. However, the prediction interval is extremely wide.
Sources: en.wikipedia.org
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.
The compound is generally handled as light-sensitive and stored cold and dry. Stability in solution depends on solvent, concentration, and storage time. Specific degradation rates are not fully standardized.
Limited water solubility affects formulation for cell and animal studies. Organic co-solvents are often used to dissolve it. Precipitation can confound assay results if not controlled.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.